149 related articles for article (PubMed ID: 10467409)
21. Infrequent somatic mutations of the p73 gene in various human cancers.
Han S; Semba S; Abe T; Makino N; Furukawa T; Fukushige S; Takahashi H; Sakurada A; Sato M; Shiiba K; Matsuno S; Nimura Y; Nakagawara A; Horii A
Eur J Surg Oncol; 1999 Apr; 25(2):194-8. PubMed ID: 10218465
[TBL] [Abstract][Full Text] [Related]
22. Malignant transformation-related genes in meningiomas: allelic loss on 1p36 and methylation status of p73 and RASSF1A.
Nakane Y; Natsume A; Wakabayashi T; Oi S; Ito M; Inao S; Saito K; Yoshida J
J Neurosurg; 2007 Aug; 107(2):398-404. PubMed ID: 17695396
[TBL] [Abstract][Full Text] [Related]
23. Analysis of p73 and p53 gene deletions in multiple myeloma.
Schultheis B; Krämer A; Willer A; Hegenbart U; Goldschmidt H; Hehlmann R
Leukemia; 1999 Dec; 13(12):2099-103. PubMed ID: 10602435
[TBL] [Abstract][Full Text] [Related]
24. Decreased expression of the Id3 gene at 1p36.1 in ovarian adenocarcinomas.
Arnold JM; Mok SC; Purdie D; Chenevix-Trench G
Br J Cancer; 2001 Feb; 84(3):352-9. PubMed ID: 11161400
[TBL] [Abstract][Full Text] [Related]
25. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers.
Kaghad M; Bonnet H; Yang A; Creancier L; Biscan JC; Valent A; Minty A; Chalon P; Lelias JM; Dumont X; Ferrara P; McKeon F; Caput D
Cell; 1997 Aug; 90(4):809-19. PubMed ID: 9288759
[TBL] [Abstract][Full Text] [Related]
26. A common p73 polymorphism is associated with a reduced incidence of oesophageal carcinoma.
Ryan BM; McManus R; Daly JS; Carton E; Keeling PW; Reynolds JV; Kelleher D
Br J Cancer; 2001 Nov; 85(10):1499-503. PubMed ID: 11720435
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological characteristics of breast carcinomas with allelic loss in the p73 region.
Dominguez G; Silva J; Silva JM; Garcia JM; Miralles C; Rodriguez O; Jareño E; Provencio M; España P; Bonilla F
Breast Cancer Res Treat; 2000 Sep; 63(1):17-22. PubMed ID: 11079155
[TBL] [Abstract][Full Text] [Related]
28. Frequent inactivation of the p73 gene by abnormal methylation or LOH in non-Hodgkin's lymphomas.
Martinez-Delgado B; Melendez B; Cuadros M; Jose Garcia M; Nomdedeu J; Rivas C; Fernandez-Piqueras J; Benítez J
Int J Cancer; 2002 Nov; 102(1):15-9. PubMed ID: 12353228
[TBL] [Abstract][Full Text] [Related]
29. p73 gene alterations and expression in primary oral and laryngeal squamous carcinomas.
El-Naggar AK; Lai S; Clayman GL; Mims B; Lippman SM; Coombes M; Luna MA; Lozano G
Carcinogenesis; 2001 May; 22(5):729-35. PubMed ID: 11323391
[TBL] [Abstract][Full Text] [Related]
30. Loss of heterozygosity, allele silencing and decreased expression of p73 gene in breast cancers: prevalence of alterations in inflammatory breast cancers.
Ahomadegbe JC; Tourpin S; Kaghad M; Zelek L; Vayssade M; Mathieu MC; Rochard F; Spielmann M; Tursz T; Caput D; Riou G; Bénard J
Oncogene; 2000 Nov; 19(47):5413-8. PubMed ID: 11103943
[TBL] [Abstract][Full Text] [Related]
31. Mutational analysis of the p73 gene in human breast cancers.
Shishikura T; Ichimiya S; Ozaki T; Nimura Y; Kageyama H; Nakamura Y; Sakiyama S; Miyauchi M; Yamamoto N; Suzuki M; Nakajima N; Nakagawara A
Int J Cancer; 1999 Jun; 84(3):321-5. PubMed ID: 10371354
[TBL] [Abstract][Full Text] [Related]
32. Allelic loss at the p73 locus (1p36.33) is infrequent in malignant melanoma.
Herbst RA; Mommert S; Schubach J; Podewski EK; Kapp A; Weiss J
Arch Dermatol Res; 1999 Jun; 291(6):362-4. PubMed ID: 10421064
[No Abstract] [Full Text] [Related]
33. Fine deletion analysis of 1p36 chromosomal region in oral squamous cell carcinomas.
Lefeuvre M; Gunduz M; Nagatsuka H; Gunduz E; Al Sheikh Ali M; Beder L; Fukushima K; Yamanaka N; Shimizu K; Nagai N
J Oral Pathol Med; 2009 Jan; 38(1):94-8. PubMed ID: 18363675
[TBL] [Abstract][Full Text] [Related]
34. Loss of expression or mutations in the p73 tumour suppressor gene are not involved in the pathogenesis of malignant melanomas.
Kroiss MM; Bosserhoff AK; Vogt T; Buettner R; Bogenrieder T; Landthaler M; Stolz W
Melanoma Res; 1998 Dec; 8(6):504-9. PubMed ID: 9918412
[TBL] [Abstract][Full Text] [Related]
35. The p73 locus is commonly deleted in non-Hodgkin's lymphomas.
Stoffel A; Filippa D; Rao PH
Leuk Res; 2004 Dec; 28(12):1341-5. PubMed ID: 15475076
[TBL] [Abstract][Full Text] [Related]
36. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
37. Wild type p73 overexpression and high-grade malignancy in breast cancer.
Dominguez G; Silva JM; Silva J; Garcia JM; Sanchez A; Navarro A; Gallego I; Provencio M; España P; Bonilla F
Breast Cancer Res Treat; 2001 Apr; 66(3):183-90. PubMed ID: 11510689
[TBL] [Abstract][Full Text] [Related]
38. Variable expression and absence of mutations in p73 in primary neuroblastoma tumors argues against a role in neuroblastoma development.
Ejeskär K; Sjöberg RM; Kogner P; Martinsson T
Int J Mol Med; 1999 Jun; 3(6):585-9. PubMed ID: 10341287
[TBL] [Abstract][Full Text] [Related]
39. Analysis of p73 gene in meningiomas with deletion at 1p.
Lomas J; Bello MJ; Arjona D; Gonzalez-Gomez P; Alonso ME; de Campos JM; Vaquero J; Ruiz-Barnes P; Sarasa JL; Casartelli C; Rey JA
Cancer Genet Cytogenet; 2001 Aug; 129(1):88-91. PubMed ID: 11520574
[TBL] [Abstract][Full Text] [Related]
40. Ovarian cancer has frequent loss of heterozygosity at chromosome 12p12.3-13.1 (region of TEL and Kip1 loci) and chromosome 12q23-ter: evidence for two new tumour-suppressor genes.
Hatta Y; Takeuchi S; Yokota J; Koeffler HP
Br J Cancer; 1997; 75(9):1256-62. PubMed ID: 9155043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
